|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
HEMATOPOIESIS
From the Department of Medicine, Indiana University
School of Medicine, Indianapolis, IN.
Recent interest in bone marrow (BM) transplantation in
nonconditioned or minimally conditioned recipients warrants
investigation of homing patterns of transplanted hematopoietic
progenitor cells (HPCs) in irradiated and nonirradiated recipients. To
this end, phenotypically defined populations of BM cells were tracked
in lethally irradiated or nonirradiated mice at 1, 3, 6, and 24 hours after transplantation. Recovery of transplanted cells at all time points was higher in BM of nonirradiated mice, similar to earlier suggestions. The percentage of lineage-negative Sca-1+
cells and Sca-1+ cells expressing CD43, CD49e, and CD49d
steadily increased in BM of nonirradiated mice up to 24 hours, while
fluctuating in irradiated mice. Cell cycle status and BrdU
incorporation revealed that less than 20% of Sca-1+ cells
and fewer Sca-1+lin Homing, engraftment, and fate of transplanted
hematopoietic stem cells (HSCs) remain poorly understood phenomena.
While some studies support the specificity of certain components of the
homing process, such as chemotaxis, intravasation, anchorage,
survival, and proliferation of transplanted HSCs,1-8 other
studies show no differences in the seeding efficiencies of
mature9 and primitive bone marrow (BM) stem cell
subsets10 or in the distribution of BM-homed cells in
secondary recipients,11 suggesting that homing is not specific.
The majority of in vivo tracking studies have focused on
examining the trafficking and cycling activity of phenotypically undefined populations of BM cells, with little regard for phenotypic characterization of donor cells homing to specific organs. It is
possible that HSCs, which constitute less than 1% of graft cells, may
proficiently home to BM, but that their specific homing is concealed by
the massive movement of the large cohort of other, more mature BM
cells. Studies examining homing of colony-forming cells1-4,6,7 may not accurately reflect the homing of
long-term repopulating cells.12-15 Examinations of
populations of cells defined on the basis of stem cell
phenotype8 are beginning to show a different, possibly
more specific, picture of homing. Identification of the adhesion
molecule repertoire of primitive hematopoietic progenitor cells (HPCs)
homing to the BM shortly after transplantation may provide evidence of
adhesion molecules potentially involved in trafficking, homing, and
lodging of transplanted HSCs in the BM and may outline a sequential
requirement of different adhesion molecules at different stages of homing.
Investigations into the homing of HSCs following transplantation have
most commonly been performed in myeloablated recipients. Increased
vascular permeability resulting from radiation damage of endothelial
and stromal cells16 may lead to nonspecific seeding of
transplanted cells in various organs based largely on tissue mass and
vascularity. Studies showing broader tissue distribution of donor cells
in irradiated recipients11,17,18 and greater recovery of
donor cells in BM of nonmyeloablated murine recipients2,11 suggest more efficient homing or better survival of primitive HPCs in
nonmyeloablated marrow. Homing patterns of primitive HPCs in
nonmyeloablated recipients may better portray natural trafficking patterns of HSCs in vivo and, as such, may serve as tools to study natural movement of HPCs between the marrow and periphery. Furthermore, the notion that marrow spaces or "niches" need to be created for successful engraftment of donor HPCs has been recently challenged by
studies demonstrating successful engraftment in nonconditioned or
minimally conditioned murine and human recipients.19-24
These studies warrant further investigation of the fate and homing
patterns of transplanted HPCs in nonmyeloablated or minimally
myeloablated recipients.
In the present work, trafficking patterns of primitive HPCs were mapped
in the first 24 hours after transplantation of grafts consisting of
either unfractionated low-density BM cells or purified Sca-1+lin Mice
Donor cells
Primary short-term (1°ST) cell tracking Female recipient C57BL/6 or B6.BoyJ mice between 10 and 12 weeks of age were lethally irradiated with 950 cGy administered in a single dose from a 137Cs gamma irradiator (GammaCell 40; Nordion International, Kanata, ON, Canada) 17.5 to 20 hours prior to transplantation (mean = 18.5 hours). Irradiated or nonirradiated mice received transplants via tail vein injections of 1 × 104 to 1 × 108 LDBM donor cells or 4 × 104 to 3 × 105 purified ENG cells. In experiments where BM-homed ENG cells were isolated and assayed for long-term engraftment potential, 1°ST-irradiated recipients were injected with at least 1 × 105 graft cells, while nonirradiated mice received at least 2 × 105 purified cells to facilitate donor cell isolation. Mice were killed 1, 3, 6, and 20 to 24 hours later, and BM, spleen, peripheral blood (PB), lung, and liver were collected and single-cell suspensions prepared and lysed. Lysed cells from LDBM transplants were analyzed for donor cell recovery, primitive phenotype, adhesion molecule expression, cell cycle status, and proliferation history, while lysed cells from ENG transplants were analyzed for donor cell recovery and engraftment potential in serial transplantations.Calculation of recovery of donor cells The frequency of donor cells falling within a light scatter gate including lymphocytes and large granular cells, was determined for each harvested tissue, based on the background fluorescence of cells from unmanipulated mice. This frequency was multiplied by the total number of cells in each tissue, then divided by the number of cells in the original graft to calculate the recovery of total transplanted cells. The number of BM cells harvested from both tibias and femurs was considered to represent 18.7% of total murine marrow, or 40% if humeri and pelvic bones were also included.28 The total number of PB cells was calculated assuming the total PB volume to be 2 mL per mouse.29 Because of the low frequency of detectable donor cells when ENG cells were injected, flow cytometric files containing 2 × 105 to 1 × 106 events were saved and the frequency of donor cells calculated manually using event count.Adhesion molecule and lineage analysis of harvested donor cells Harvested BM cells from recipients of LDBM grafts were stained with Sca-1 and biotinylated antibodies to either CD11a (clone 2D7), CD43 (clone S7), CD44 (clone IM7), CD49d (clone 9C10), CD49e (clone 5H10-27; MFR5), CD31 (clone MEC 13.3), CD62L (clone MEL-14), or CD3 and CD45R/B220. Biotinylated antibodies were developed with streptavidin-allophycocyanin (APC; Molecular Probes). Donor cells were distinguished from recipient by PKH2, PKH26, CFSE, or appropriate CD45.1 or CD45.2 staining as described above. All antibodies were from BD PharMingen (San Diego, CA). Donor cells exhibiting small light scatter properties characteristic of primitive cells were gated and examined for Sca-1 expression and primitive phenotype (CD3 CD45R/B220) or adhesion
molecule expression using a FACScan or FACSCalibur (Becton Dickinson
Immunocytometry Systems [BDIS], San Jose, CA). Between
1 × 104 and 5 × 105 events were acquired
per sample. To avoid saving very large files, in some cases only
donor-positive events were saved during flow cytometric acquisition.
Serial transplantation studies BM-homed donor cells from 1°ST recipients of ENG cells were isolated by flow cytometry, and 50 to 200 of these cells, along with 1 × 105 competitor LDBM cells of recipient origin, were transplanted into primary long-term (1°LT) congenic recipients within 3 hours of receiving lethal irradiation in a split dose of 700 cGy + 350 cGy 4 hours apart. 1°LT recipients were bled from the tail vein monthly for 6 to 7 months for analysis of donor-derived hematopoiesis by determining the percentage of CD45.1+ or CD45.2+ PB leucocytes. In some experiments, 1°LT recipients were killed 6 to 7 months after transplantation, and 2-5 × 106 LDBM cells were transplanted into lethally irradiated (700 cGy + 350 cGy) secondary LT (2°LT) recipients without competitor cells. 2°LT recipients were bled from the tail vein monthly for 6 to 7 months for analysis of donor-derived hematopoiesis. In some experiments, donor-derived cells from 1°LT and 2°LT recipients were analyzed 6 to 7 months after transplantation for the percentage of lineage cells using phycoerythrin (PE)-conjugated antibodies specific for CD3+, CD45/B220+, Gr-1+, and Mac-1+ cells.Cell cycle status Fresh cells or donor-derived Sca-1+ cells from harvested BM and spleen of transplant recipients were isolated by cell sorting using a FACStarplus or FACSVantage SE flow cytometer (BDIS) and analyzed for cell cycle position using propidium iodide (PI) as previously described.30 The low number of donor Sca-1+ cells attainable from PB precluded cell cycle analyses of these cells.BrdU administration Mice received 4 intraperitoneal injections of 100 µg/g BrdU in 200 µL H2O at 36, 24, 12, and 1 hour before receiving transplants of LDBM cells. Mice destined for 24-hour homing studies received an additional injection of BrdU 12 hours after BM transplantation.BrdU staining Donor-derived cells from mice administered BrdU were assayed for BrdU uptake by 2 different methods. In the first, donor Sca-1+ cells from BM or spleen at 1, 3, 6, or 24 hours after transplantation were isolated by flow cytometric cell sorting and then stained for BrdU as previously described.31 Briefly, sorted Sca-1+ cells were fixed with 1% formaldehyde (Tousimis, Rockville, MD) and 0.2% Tween 20 (Sigma) in phosphate-buffered saline (PBS) for at least 10 minutes but no longer than 24 hours. Cells were then treated with 4 M HCl in 0.2% Tween 20/PBS for 30 minutes at 37°C, washed with 0.1 M sodium borate (Sigma), and then washed with 0.2% Tween 20/PBS. Cells were then stained with fluorescein isothiocyanate (FITC)-conjugated anti-BrdU antibody (BD PharMingen). Prior to acquisition, PI was added to a final concentration of 10 µg/mL for 60 minutes.In the second method, bulk unsorted BM or spleen cells were analyzed flow cytometrically using 4-color analysis for donor origin, surface phenotype, and BrdU incorporation simultaneously as previously described32 with slight modifications. Briefly, cells were stained with the appropriate anti-CD45.1-PE or anti-CD45.2-PE to identify donor cells, biotinylated Sca-1, anti-CD3-cychrome, and anti-B220-cychrome, followed by streptavidin-APC, then fixed with 1% formaldehyde overnight. In some experiments Sca-1-cychrome was used with biotinylated lineage markers developed with streptavidin-APC. All antibodies were from BD PharMingen. Cells were permeabilized with 0.1% saponin/PBS (Perm Buffer) plus 2% formaldehyde for 10 minutes at room temperature, pelleted, then permeabilized with 0.2% Tween 20/PBS for 10 minutes at room temperature, washed with Perm Buffer, and incubated with 100 to 300 Kunitz units of DNAseI (Sigma) in Hanks balanced salt solution for 60 minutes at 37°C. Cells were washed in Perm Buffer and then stained with anti-BrdU-FITC (BD PharMingen). Statistical analysis Data are expressed as the mean ± SEM where applicable. Differences between groups were analyzed using an unpaired 2-sided t test. Differences in chimerism were analyzed by repeated measures analysis of variance using an arcsine transformation. A probability value of less than 0.05 was considered significant for all tests.
Identification of graft sizes allowing for adequate detection of homed cells As a first step in examining the distribution of donor cells in vivo following transplantation, the number of donor cells homing to BM, spleen, or remaining in PB after transplantation was determined. Log increasing doses of donor LDBM cells from 1 × 104 to 1 × 108 cells were injected into single irradiated mice and allowed to home for 3 hours. The frequency of donor cells detected at 3 hours in all 3 tissues examined positively correlated with the number of graft cells injected (Table 1). Based on these results, subsequent experiments were designed to deliver between 17 and 90 × 106 cells per graft.
Recovery of donor cells in LDBM transplants Total recovery (BM + spleen + PB) of graft cells was calculated based on the frequency of donor cells detected in BM, spleen, and PB, and the total number of nucleated cells within each tissue, as described in "Materials and methods." The frequency of donor cells ranged from 0.3% in nonirradiated spleen at 24 hours to up to 39% of total cells in 1-hour irradiated PB. The cellularity of irradiated BM, spleen, and PB in recipient mice ranged between 24-55 × 106, 3-8 × 106, and 1-4 × 106, respectively, depending on the time of analysis after irradiation (range, 19.5 hours for 1-hour time points to 42.5 hours for 20- to 24-hour time points). Cellularity of nonirradiated BM, spleen, and PB averaged 212 × 106, 72 × 106, and 14 × 106, respectively.Total recovery of donor cells did not vary significantly between 1 and 24 hours in either transplant setting but was, however, slightly higher in nonirradiated recipients at each time point compared with irradiated mice (bars in Figure 1A-B), in agreement with previous suggestions.2,11 Total recovery in nonirradiated mice was significantly higher than that in irradiated mice when data from all 4 time points were pooled together (7.6 ± 0.6, n = 18; and 5.6 ± 0.3, n = 38, respectively, P < .05). When individual tissues were examined in both transplant settings, recovery of donor cells was highest in BM from 3 to 24 hours after transplantation (Figure 1A-B), reflecting either the specificity of BM homing of graft cells or the relatively larger mass of this tissue, or both. Distribution of donor cells differed with time in the 2 transplant settings. While recovery of donor cells in BM increased rapidly and reached a plateau by 3 hours in irradiated mice, recovery in nonirradiated marrow remained fairly constant. Recovery in nonirradiated BM was significantly greater than that in irradiated BM when data from all 4 time points were pooled together (5.7 ± 0.5%, n = 18; and 3.70% ± 0.2, n = 38; respectively, P < .05). Interestingly, while recovery in irradiated spleen did not change significantly with time, donor cells accumulated initially in nonirradiated spleen and then declined at later time points (Figure 1A-B). As expected, cell recovery was highest in PB at 1 hour but declined thereafter. In initial experiments, lung and liver were also examined for the recovery of donor cells, but since total recovery in the 2 tissues combined was typically less than 0.1%, these tissues were omitted from subsequent analyses. Primitive phenotype and adhesion molecule phenotype of BM-homed Sca-1+ cells To gain insight into trafficking of primitive HPCs and adhesion molecules possibly involved in HPC homing, donor-derived Sca-1+ cells homing to BM were phenotyped for lineage and adhesion molecule expression at 1, 3, 6, and 20 to 24 hours after transplantation. Figure 2 shows representative dot plots and histograms for a typical adhesion molecule analysis of donor Sca-1+ cells found in BM 1 hour after transplantation. All phenotypic analyses were performed on donor Sca-1+ cells exhibiting light scatter properties characteristic of primitive HPCs (low side and forward scatter). Frequency of lineage-negative, CD43+, CD49e+, CD49d+, and CD62L+ BM-homed donor Sca-1+ cells increased in nonirradiated mice from 1 to 24 hours after transplantation, while these frequencies mostly fluctuated in irradiated mice (Figure 3A-E). CD11a and CD44 were present on 95% to 100% of donor Sca-1+ cells in the graft and all tissues examined and did not differ in irradiated and nonirradiated mice (n = 3-11, data not shown). At 20 to 24 hours, a slightly higher frequency of Sca-1+ cells in nonirradiated mice expressed CD43, CD49e, and CD49d and were CD3CD45R/B220 (Figure 3), matching a
phenotype enriched for long-term engrafting cells.25
Interestingly, while approximately 45% to 55% of donor Sca-1+ graft cells and those remaining in PB at 1 hour
expressed CD62L, the majority of Sca-1+ cells recovered
from BM at 1 hour lacked CD62L expression (Figure 3E).
Recovery and serial transplantation of donor cells in ENG cell transplants To examine the trafficking of primitive HPCs more directly, grafts composed of 4 × 104 to 3 × 105 sorted cells enriched for stem cell phenotype (Sca-1+linCD49e+ or
Sca-1+linCD62L) were tracked at
20 hours in irradiated and nonirradiated 1°ST mice. Figure
4 shows representative dot plots of
typical analyses of donor cells found in BM and spleen tissues and the
range of frequencies of donor cells detected in all experiments in BM, spleen, and PB. Similar to increased recovery of graft cells in BM of
nonirradiated recipients when LDBM grafts were transplanted, recovery
of purified ENG phenotypes was higher in nonirradiated mice, while
recovery in spleen and PB was similar in the 2 settings (Figure
5).
We next defined the in vivo trafficking patterns of HSCs in irradiated
or nonirradiated mice by examining the long-term repopulating potential
of BM-homed donor cells 20 hours after injection of ENG cells. To this
end, BM-homed donor cells were isolated from irradiated or
nonirradiated 1°ST recipients, and 50 to 200 of these cells
transplanted competitively into 1°LT-irradiated recipients. No
significant differences in chimerism were detected in 1°LT recipients
of BM-homed donor cells from irradiated or nonirradiated 1°ST mice
(Figure 6A) up to 6 months after
transplantation. However, when 2-5 × 106 LDBM cells from
1°LT recipients were transplanted into 2°LT mice, donor-derived
chimerism was significantly greater in recipients of BM-homed cells
from nonirradiated 1°ST recipients (Figure 6B), suggesting more
efficient homing or better survival of primitive HPCs in
nonmyeloablated marrow. BM-homed cells from both irradiated and
nonirradiated 1°ST mice were equally effective in providing multilineage engraftment in both 1°LT and 2°LT recipients and did not apparently differ in their relative contribution to either myeloid or lymphoid lineages (data not shown).
Cell cycle status To examine the activation of primitive HPCs following transplantation, donor Sca-1+ cells from BM and spleen were analyzed for cell cycle status by PI staining of sorted cells or by BrdU incorporation. Figure 7 shows representative BrdU and cell cycle analysis of BM-homed Sca-1+ and Sca-1+lin cells from
irradiated and nonirradiated recipients 6 hours after injection of
LDBM. More than 95% of donor Sca-1+ cells isolated from BM
or spleen were in G0/G1 regardless of time of analysis or irradiation
status, a frequency similar to that of Sca-1+ cells in the
original graft (Figure 8A-B). No
significant differences in G0/G1 status were noted between irradiated
and nonirradiated mice or at different times of analysis.
Less than 22% of BM- and spleen-homed Sca-1+ cells from
irradiated or nonirradiated mice were found to contain BrdU when
analyzed between 1 and 24 hours, although this frequency declined by 24 hours in irradiated mice (Figure 8C-D). The more primitive
Sca-1+lin
In this report, we define the trafficking patterns and
adhesion molecule repertoire of classes of phenotypically defined
primitive BM cells early after their transplantation into lethally
irradiated or nonirradiated recipient mice. Higher recovery of
transplanted cells and increased incidence of CD43+,
CD49e+, CD49d+, and lin The increase in CD43, CD49e, and CD49d expression on BM-homed Sca-1+ cells in nonirradiated mice correlates with the enhanced engraftment potential of BM-homed cells in nonirradiated mice and supports our earlier studies25 and those of others,33,34 suggesting an importance of these molecules in homing or engraftment of primitive HPCs. Whether these molecules are involved in homing and/or anchorage of primitive HPCs to BM or in modulating a yet-to-be-identified parameter important in engraftment remains to be determined. Nevertheless, these data suggest that while homing in myeloablated recipients may represent a random process due to radiation damage of stroma and/or endothelial cells, homing in nonmyeloablated recipients may not only be more specific, but may also better portray natural trafficking patterns of HSCs in vivo. Recent studies in parabiotic mice36 support the notion that a small number of HSC naturally traverse between blood and marrow in normal mice, further suggesting the existence of established migratory pathways for HSC between blood and BM in nonablated hosts. Our data suggest that these pathways are at least partially disrupted after lethal irradiation, such that fewer HSC home to, or survive within, an irradiated BM microenvironment. The reported generalized up-regulation of adhesion molecule counterreceptors, such as VCAM,37,38 ICAM,38,39 and PECAM39 after irradiation may contribute to nonspecific seeding of transplanted HSC to sites other than BM. Preliminary studies in our laboratory suggest that shortened time intervals between radiation dosing and transplantation may have favorable outcomes for homing and possibly engraftment, supporting the notion that radiation-sensitive microenvironmental cues may be involved in the homing process and fate of transplanted cells. Whether radiation-induced bystander effects (reviewed in Mothersill and Seymour40) negatively impact the function of transplanted primitive HPC and account for some of our observed differences in homing and engraftment in irradiated and nonirradiated mice is unknown. Nevertheless, our finding that graft cells home more efficiently to nonirradiated BM may partially explain the recent successes of BM transplantation in this scenario.19-24 Better understanding of homing mechanisms may open these areas to manipulation and the possible design of protocols aimed at enhancing trafficking of transplanted HSCs to BM, which may be especially beneficial to those patients undergoing minimally ablated BM transplantation. This report examined the adhesion molecule repertoire of phenotypically
defined Sca-1+ cells early after transplantation. Although
analysis of adhesion molecule expression on
Sca-1+lin Analyses of cycling activity of transplanted cells within the first 48 hours of transplantation have yielded varying results,2,5-7,11,36,37 possibly due to differences in the methodology used for cell cycle determination. While assays examining loss of fluorescence of membrane dyes2,6,11 examine proliferation history of transplanted cells and are subject to dye loss by means other than proliferation, those using DNA-specific stains such as PI36 reveal a snapshot of cycling status at time of analysis. We have attempted to assay cycling status of transplanted cells through the use of both BrdU labeling and PI analysis to document both proliferation history and instantaneous cell cycle position. While our own data and those of others using PI show more than 93% of BM- and spleen-homed murine5 and human36 donor cells in G0/G1 up to 24 hours after transplantation, we found that up to 20% of these cells had incorporated BrdU. That PI and BrdU cell cycle analyses do not always correspond is known and possibly is due to incorporation of BrdU into G1-phase cells. Alternatively, if the decreased percentage of BrdU+ cells observed in irradiated mice at 24 hours represents true loss of cycling cells, these data may represent proliferation inhibition and subsequent apoptosis of transplanted cells in active phases of cell cycle, as we have previously documented.36 The slightly higher fraction of cycling cells detected in nonirradiated mice, together with the increased recovery of long-term repopulating cells in BM of nonirradiated mice, suggests the possibility of enhanced survival of transplanted primitive HPCs in a nonirradiated environment. Whether proliferation inhibition and apoptosis of transplanted cycling cells are secondary to effects of radiation remains unknown, but are intriguing possibilities to explain the observed increase in recovery of transplantable HSCs in the BM of nonirradiated mice 20 hours after transplantation.
Submitted September 17, 2001; accepted July 22, 2002.
Supported in part by National Institutes of Health grant RO1 HL62200.
The publication costs of this article were defrayed in part by page charge payment. Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18 U.S.C. section 1734.
Reprints: Christie M. Orschell-Traycoff, Department of Medicine, Indiana University School of Medicine, 1044 W Walnut St, R4-202, Indianapolis, IN 46202-5254; e-mail: corschel{at}iupui.edu.
1.
Aizawa S, Tavassoli M.
Molecular basis of the recognition of intravenously transplanted hemopoietic cells by bone marrow.
Proc Natl Acad Sci U S A.
1988;85:3180-3183 2. Hendrikx P, Martens A, Hagenbeek A, Keij J, Visser J. Homing of fluorescently labeled murine hematopoietic stem cells. Exp Hematol. 1996;24:129-140[Medline] [Order article via Infotrieve].
3.
Vermeulen M, Le Pesteur F, Gagnerault M, et al.
Role of adhesion molecules in the homing and mobilization of murine hematopoietic stem and progenitor cells.
Blood.
1998;92:894-900
4.
Szilvassy S, Bass M, Van Zant G, Grimes B.
Organ-selective homing defines engraftment kinetics of murine hematopoietic stem cells and is compromised by ex vivo expansion.
Blood.
1999;93:1557-1566
5.
Lanzkron S, Collector M, Sharkis S.
Hematopoietic stem cell tracking in vivo: a comparison of short-term and long-term repopulating cells.
Blood.
1999;93:1916-1921 6. Oostendorp R, Ghaffari S, Eaves C. Kinetics of in vivo homing and recruitment into cycle of hematopoietic cells are organ-specific but CD44-independent. Bone Marrow Transplant. 2000;26:559-566[CrossRef][Medline] [Order article via Infotrieve].
7.
Papayannopoulou T, Craddock C, Nakamoto B, Priestley G, Wolf N.
The VLA4/VCAM adhesion pathway defines contrasting mechanisms of lodgement of transplanted murine hemopoietic progenitors between bone marrow and spleen.
Proc Natl Acad Sci U S A.
1995;92:9647-9651 8. Krause D, Theise N, Collector M, et al. Multi-organ, multi-potential engraftment by a single bone marrow-derived stem cell. Cell. 2001;105:369-377[CrossRef][Medline] [Order article via Infotrieve].
9.
Shaaban A, Kim H, Milner R, Flake A.
A kinetic model for the homing and migration of prenatally transplanted marrow.
Blood.
1999;94:3251-3257
10.
van der Loo J, Ploemacher R.
Marrow- and spleen-seeding efficiencies of all murine hematopoietic stem cell subsets are decreased by preincubation with hematopoietic growth factors.
Blood.
1995;85:2598-2606 11. Cui J, Wahl R, Shen T, et al. Bone marrow cell trafficking following intravenous administration. Br J Haematol. 1999;107:895-902[CrossRef][Medline] [Order article via Infotrieve]. 12. Hodgson G, Bradley T. Properties of haematopoietic stem cells surviving 5-fluorouracil treatment: evidence for a pre-CFU-S cell? Nature. 1979;281:381-382[Medline] [Order article via Infotrieve]. 13. Ploemacher R, Brons R. Separation of CFU-S from primitive cells responsible for reconstitution of the bone marrow hemopoietic stem cell compartment following irradiation: evidence for a pre-CFU-S cell. Exp Hematol. 1989;17:263-266[Medline] [Order article via Infotrieve]. 14. Jones RJ, Wagner JE, Celano P, Zicha MS, Sharkis SJ. Separation of pluripotent haematopoietic stem cells from spleen colony-forming units. Nature. 1990;347:188-189[CrossRef][Medline] [Order article via Infotrieve].
15.
Zhao Y, Lin Y, Zhan Y, et al.
Murine hematopoietic stem cell characterization and its regulation in BM transplantation.
Blood.
2000;96:3016-3022 16. Shirota T, Tavassoli M. Alterations of bone marrow sinus endothelium induced by ionizing irradiation: implications in the homing of intravenously transplanted marrow cells. Blood Cells. 1992;18:197-214[Medline] [Order article via Infotrieve]. 17. Bolante-Cervantes R, Li S, Sahota A, et al. Pattern of localization of primitive hematopoietic cells in vivo using a novel mouse model. Exp Hematol. 1999;27:1346-1352[CrossRef][Medline] [Order article via Infotrieve]. 18. Hayakawa J, Moriya N, Shiohara T. Adult thymus contains dendritic epidermal T cell precursors that home to the epidermis in irradiated, but not in normal, mice. Cell Immunol. 1996;174:190-198[CrossRef][Medline] [Order article via Infotrieve]. 19. Micklem H, Clarke C, Evans E, Ford C. Fate of chromosome-marked mouse bone marrow cells transfused into normal syngeneic recipients. Transplantation. 1968;6:299-302[Medline] [Order article via Infotrieve]. 20. Takada A, Takada Y, Ambrus J. Proliferation of donor spleen and bone-marrow cells in the spleens and bone marrows of unirradiated and irradiated adult mice. Proc Soc Exp Biol Med. 1971;136:222-226[CrossRef][Medline] [Order article via Infotrieve]. 21. Quesenberry P, Ramshaw H, Crittenden R, et al. Engraftment of normal murine marrow into nonmyeloablated host mice. Blood Cells. 1994;20:348-350[Medline] [Order article via Infotrieve].
22.
Stewart F, Crittenden R, Lowry P, Pearson-White S, Quesenberry P.
Long-term engraftment of normal and post 5-fluorouracil murine marrow into normal myeloablated mice.
Blood.
1993;81:2566-2571
23.
Brecher G, Ansell J, Micklem H, Tjio J-H, Cronkite E.
Special proliferative sites are not needed for seeding and proliferation of transfused bone marrow cells in normal syngeneic mice.
Proc Natl Acad Sci U S A.
1982;79:5085-5087 24. Wu D, Keating A. Hematopoietic stem cells engraft in untreated transplant recipients. Exp Hematol. 1993;21:251-256[Medline] [Order article via Infotrieve].
25.
Orschell-Traycoff C, Hiatt K, Dagher R, et al.
Homing and engraftment potential of Sca
26.
Traycoff CM, Kosak ST, Grigsby S, Srour EF.
Evaluation of ex vivo expansion potential of cord blood and bone marrow hematopoietic progenitor cells using cell tracking and limiting dilution analysis.
Blood.
1995;85:2059-2068 27. Srour E, Bregni M, Traycoff C, et al. Long-term hematopoietic culture-initiating cells are more abundant in mobilized peripheral blood grafts than in bone marrow but have a more limited ex vivo expansion potential. Blood Cells Mol Dis. 1996;22:68-81[CrossRef][Medline] [Order article via Infotrieve]. 28. Boggs D. The total marrow mass of the mouse: a simplified method of measurement. Am J Hematol. 1984;16:277-286[Medline] [Order article via Infotrieve].
29.
Chervenick P, Boggs D, Marsh J, Cartwright G, Wintrobe M.
Quantitative studies of blood and bone marrow neutrophils in normal mice.
Am J Physiol.
1968;215:353-360 30. Srour EF, Brandt JE, Leemhuis T, Ballas CB, Hoffman R. Relationship between cytokine-dependent cell cycle progression and MHC class II antigen expression by human CD34+ HLA-DR- bone marrow cells. J Immunol. 1992;148:815-820[Abstract]. 31. Bradford G, Williams B, Rossi R, Bertoncello I. Quiescence, cycling, and turnover in the primitive hematopoietic stem cell compartment. Exp Hematol. 1997;25:445-453[Medline] [Order article via Infotrieve]. 32. Houck D, Loken M. Simultaneous analysis of cell surface antigens, bromodeoxyuridine incorporation and DNA content. Cytometry. 1985;6:531-538[CrossRef][Medline] [Order article via Infotrieve]. 33. Moore T, Huang S, Terstappen LW, Bennett M, Kumar V. Expression of CD43 on murine and human pluripotent hematopoietic stem cells. J Immunol. 1994;153:4978-4987[Abstract]. 34. van der Loo JCM, Xiao X, McMillin D, et al. VLA-5 is expressed by mouse and human long-term repopulating hematopoietic cells and mediates adhesion to extracellular matrix protein fibronectin. J Clin Invest. 1998;102:1051-1061[Medline] [Order article via Infotrieve].
35.
Sato T, Laver J, Ogawa M.
Reversible expression of CD34 by murine hematopoietic stem cells.
Blood.
1999;94:2548-2554
36.
Jetmore A, Plett P, Tong X, et al.
Homing efficiency, cell cycle kinetics, and survival of quiescent and cycling human CD34+ cells transplanted into conditioned NOD/SCID recipients.
Blood.
2002;99:1585-1593
37.
Nilsson SK, Dooner MS, Quesenberry PJ.
Synchronized cell-cycle induction of engrafting long-term repopulating stem cells.
Blood.
1997;90:4646-4650 38. Tsujino K, Kodama A, Kanaoka N, Maruta T, Kono M. Expression of pulmonary mRNA encoding ICAM-1, VCAM-1, and P-selectin following thoracic irradiation in mice. Radiat Med. 1999;17:283-287[Medline] [Order article via Infotrieve]. 39. Quarmby S, Hunter R, Kumar S. Irradiation induced expression of CD31, ICAM-1 and VCAM-1 in human microvascular endothelial cells. Anticancer Res. 2000;20:3375-3381[Medline] [Order article via Infotrieve]. 40. Mothersill C, Seymour C. Radiation-induced bystander effects: past history and future directions. Radiat Res. 2001;155:759-767[CrossRef][Medline] [Order article via Infotrieve].
41.
Sato T, Laver J, Ogawa M.
Reversible expression of CD34 by murine hematopoietic stem cells.
Blood.
1999;94:2548-2554
42.
Jetmore A, Plett P, Tong X, et al.
Homing efficiency, cell cycle kinetics, and survival of quiescent and cycling human CD34+ cells transplanted into conditioned NOD/SCID recipients.
Blood.
2002;99:1585-1593
43.
Nilsson SK, Dooner MS, Quesenberry PJ.
Synchronized cell-cycle induction of engrafting long-term repopulating stem cells.
Blood.
1997;90:4646-4650
© 2002 by The American Society of Hematology.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
|
 |
|
  D. Bhattacharya, A. Czechowicz, A.G. L. Ooi, D. J. Rossi, D. Bryder, and I. L. Weissman Niche recycling through division-independent egress of hematopoietic stem cells J. Exp. Med., November 23, 2009; 206(12): 2837 - 2850. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Yu, Y. Yuan, H. Shen, and T. Cheng Hematopoietic stem cell exhaustion impacted by p18INK4C and p21Cip1/Waf1 in opposite manners Blood, February 1, 2006; 107(3): 1200 - 1206. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. E. Broxmeyer, C. M. Orschell, D. W. Clapp, G. Hangoc, S. Cooper, P. A. Plett, W. C. Liles, X. Li, B. Graham-Evans, T. B. Campbell, et al. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist J. Exp. Med., April 18, 2005; 201(8): 1307 - 1318. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. E. Daldrup-Link, M. Rudelius, G. Piontek, S. Metz, R. Brauer, G. Debus, C. Corot, J. Schlegel, T. M. Link, C. Peschel, et al. Migration of Iron Oxide-labeled Human Hematopoietic Progenitor Cells in a Mouse Model: In Vivo Monitoring with 1.5-T MR Imaging Equipment Radiology, January 1, 2005; 234(1): 197 - 205. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Perry, H. Wang, L. J. Pierce, A. M. Yang, S. Tsai, and G. J. Spangrude L-selectin defines a bone marrow analog to the thymic early T-lineage progenitor Blood, April 15, 2004; 103(8): 2990 - 2996. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Ito, Y. Takeuchi, J. Shaffer, and M. Sykes Local irradiation enhances congenic donor pluripotent hematopoietic stem cell engraftment similarly in irradiated and nonirradiated sites Blood, March 1, 2004; 103(5): 1949 - 1954. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Li, P. A. Plett, Y. Yang, P. Hong, B. Freie, E. F. Srour, C. M. Orschell, D. W. Clapp, and L. S. Haneline Fanconi anemia type C-deficient hematopoietic stem/progenitor cells exhibit aberrant cell cycle control Blood, September 15, 2003; 102(6): 2081 - 2084. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Plett, S. M. Frankovitz, and C. M. Orschell Distribution of marrow repopulating cells between bone marrow and spleen early after transplantation Blood, September 15, 2003; 102(6): 2285 - 2291. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
 |
 |
|||||||
 |
 |
 |
 |
 |
 |
 |
 |
||
| Copyright © 2002 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||
Top
Abstract
Introduction
indicates irradiated
1°ST; 
, nonirradiated 1°ST.
1+lin